從民國59年1月至78年12月，本院共治療98位陰莖癌的病人。包括86位下皮細胞癌（Epidermoid Carcinoma），10位疣癌（Verrucous Carcinoma），1位原位癌（Carcinoma in situ）及1位粘膜上皮細胞癌（Muco-epidermoid Carcinoma）。根據本院統計陰莖癌占所有男性癌症病患的0.34%。病人依據Jackson’s臨床分期，第一期占51.02%，第二期20.41%，第三期24.49%，第四期4.08%。本院對於陰莖癌的治療以外科手術為主，包括部分陰莖切除術（partial penectomy）及全陰莖切除術（Total penectomy）。拒絕接受陰莖切除術或較晚期的病患則接受放射線治療、化學治療或兩者合併使用。陰莖上皮細胞癌病人五年存活率：第一期71.88%，第二期45.45%，第三期26.67%，第四期0%；而陰莖疣癌病人五年之存活率平均為75%。(J Uorl R.O.C., 1: 226-232,1990)

Ninety-eight patients with carcinoma of the penis treated over a period of twenty years (1970-1989) were retrospectively analyzed. Of this patients, 86 Patients were epidermoid 10 patients were verrucous carcinoma, one patient was carcinoma in situ and one patient was muco-epidermoid carcinoma. Our series showed that the incidence of penile cancer was 0.34% of all malignant tumors in male. According to Jackson’s clinical staging, 51.02% were in stage I, 20.41% in stage II, 24.49% in stahge III and 4.08% in stage IV. Carcinoma of the penis was chiefly treated with surgical method including partial and total penectomy. Some patients who refused penectomy or advanced case were transferred to Cancer-Therapeutic Center for radiotherapy, chemotherapy or combined treatment. Five years survival rate of epidermoid carcinoma of penis was 71.88% in staghe I, 45.45% in stage II, 26.67% in stage III and 0% in stage IV. The average five years survival rate of verrucous carcinoma of penis was 75%.